GSK Stock Latest News

Acting FDA head vows to block political interference, Endpoint News says

PremiumThe Fly

2d ago

FDA issues draft guidance to help accelerated cell, gene therapies for patients

PremiumThe Fly

4d ago

GSK’s ViiV Healthcare launches PrEP Wisdom campaign

PremiumThe Fly

5d ago

Sachin Jain Reiterates Hold as Bepirovirsen’s Phase 3 Data Show Upper-Range Efficacy but Limited Eligible Patient Pool and Commercial Hurdles

PremiumRatings

8d ago

PremiumCompany AnnouncementsGSK’s mRNA Flu Vaccine Trial Reaches Key Phase 2 Milestone, Eyeing Next-Gen Seasonal Market

9d ago

Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint

The Fly

Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint

9d ago

IONS

GSK’s Long-Acting HIV Study Nears the Finish Line: What Investors Should Watch

Company Announcements

GSK’s Long-Acting HIV Study Nears the Finish Line: What Investors Should Watch

10d ago

GSK to present new data from portfolio, pipeline at ASCO Annual Meeting

PremiumThe Fly

11d ago

GSK Earnings Call Highlights Specialty Strength, H2 Tilt

PremiumCompany Announcements

11d ago

GSK’s New Sarcoma Trial Puts Fresh Spotlight on Its Oncology Pipeline

PremiumCompany Announcements

15d ago

GSK-Backed DB-1324 Trial Marks Early Progress in Advanced Gastrointestinal Cancer

PremiumCompany Announcements

15d ago

PremiumMarket NewsHow Do Currency-Hedged ETFs Work? Inside the Mechanism That Lets You Invest in Shell, Toyota, and ASML Without the FX Guesswork

17d ago

GSK Earnings Call Highlights Specialty, HIV And Pipeline

Company Announcements

GSK Earnings Call Highlights Specialty, HIV And Pipeline

17d ago

Trump Trade: Trump announces expansion of TrumpRx.gov

The Fly

Trump Trade: Trump announces expansion of TrumpRx.gov

18d ago

GSK Nears Key Hepatitis B Milestone With Completion of B-Well 1 Phase 3 Trial

PremiumCompany Announcements

19d ago

Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says

PremiumThe Fly

19d ago

Global Stocks, American Dollars: How ADRhedged™ ETFs Are Fixing the Most Overlooked Risk in International Investing

PremiumMarket News

19d ago

PremiumThe Fly

GSK announces Japan’s MHLW expanded eligible population for Arexvy

19d ago

PremiumThe FlyDavis to become acting director of CDER after Hoeg exit, Bloomberg says

22d ago

AnaptysBio price target raised to $90 from $85 at Leerink

The Fly

AnaptysBio price target raised to $90 from $85 at Leerink

22d ago

ANAB

GSK’s B-Well 2 Hepatitis B Trial Reaches Completion, Setting the Stage for Key Data

Company Announcements

GSK’s B-Well 2 Hepatitis B Trial Reaches Completion, Setting the Stage for Key Data

22d ago